Evidence of increased dopamine receptor signaling in food-restricted rats

Neuroscience

Volumn 119, Issue 4, 2003, Pages 1157-1167

  Carr, K D ^a   Tsimberg, Y ^a   Berman, Y ^a   Yamamoto, N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenylyl cyclase; c Fos; GTP S; Quinpirole; SKF 82958

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADENYLATE CYCLASE; CYCLIC AMP; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FLUORIDE SODIUM; FORSKOLIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MANGANESE CHLORIDE; POSTSYNAPTIC RECEPTOR; PROTEIN C FOS; QUINPIROLE; SULFUR 35;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CATALYSIS; CAUDATE NUCLEUS; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; DRUG EXPOSURE; ENZYME ACTIVATION; EXPERIMENT; FEEDING; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; INJECTION; MALE; MOTOR ACTIVITY; NERVE; NERVE MEMBRANE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUTAMEN; RAT; SIGNAL TRANSDUCTION; STIMULATION; TRANSCRIPTION REGULATION;

EID: 0038094515     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00227-6     Document Type: Article

References (80)

1. Auman J.T., Seidler F.J., Slotkin T.A. Neonatal chlorpyrifos exposure targets multiple proteins governing the hepatic adenylyl cyclase signaling cascade implications for neurotoxicity . Dev Brain Res. 121:2000;19-27.
2. Bassareo V., Di Chiara G. Differential responsiveness of dopamine transmission to food stimuli in nucleus accumbens shell/core compartments. Neuroscience. 89:1999;637-641.
3. Bauco P., Wise R.A. Synergistic effects of cocaine with lateral hypothalamic brain stimulation reward lack of tolerance or sensitization . J Pharmacol Exp Ther. 283:1997;1160-1167.
4. Bell S.M., Stewart R.B., Thompson S.C., Meisch R.A. Food-deprivation increases cocaine-induced conditioned place preference and locomotor activity in rats. Psychopharmacology. 131:1997;1-8.
5. Beninger R.J., Miller R. Dopamine D1-like receptors and reward-related incentive learning. Neurosci Biobehav Rev. 22:1998;335-345.
6. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron. 25:2000;515-532.
7. Berman Y., Devi L., Carr K.D. Effects of chronic food restriction on prodynorphin-derived peptides in rat brain regions. Brain Res. 664:1994;49-53.
8. Berretta S., Robertson H.A., Graybiel A.M. Dopamine and glutamate agonists stimulate neuron-specific expression of fos-like protein in the striatum. J Neurophysiol. 68:1992;767-777.
9. Cabeza de Vaca S., Carr K.D. Food restriction enhances the central rewarding effect of abused drugs. J Neurosci. 18:1998;7502-7510.
10. Cabib S., Orsini C., Le Moal M., Piazza P.V. Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Proc Natl Acad Sci USA. 289:2000;463-465.
11. Cai G., Zhen X., Uryu K., Friedman E. Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D2 dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats. J Neurosci. 20:2000;1849-1857.
12. Carboni E, Silvagni A, Rolando MTP, Di Chiara G (2000) Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J Neurosci 20:RC102.
13. Carr K.D. Augmentation of drug reward by chronic food restriction behavioral evidence and underlying mechanisms . Physiol Behav. 76:2002;353-364.
14. Carr K.D., Kim G.-Y., Cabeza de Vaca S. Chronic food restriction augments the central rewarding effect of cocaine and the δ-1 opioid agonist, DPDPE, but not the δ-2 agonist, deltorphin-II. Psychopharmacology. 152:2000;200-207.
15. Carr K.D., Kim G.-Y., Cabeza de Vaca S. Rewarding and locomotor-activating effects of direct dopamine receptor agonists are augmented by chronic food restriction in rats. Psychopharmacology. 154:2000;420-428.
16. Carr K.D., Kutchukhidze N. Chronic food restriction increases Fos-like immunoreactivity (FLI) induced in rat forebrain by intraventricular amphetamine. Brain Res. 861:2000;88-96.
17. Carroll M.E., Meisch R.A. Increased drug-reinforced behavior due to food deprivation. Adv Behav Pharmacol. 4:1984;47-88.
18. Cassidy F., Ahearn E., Carroll B.J. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry. 156:1999;1417-1420.
19. Choe E.S., McGinty J.F. N-methyl-D-aspartate receptors and p38 mitogen-activated protein kinase are required for cAMP-dependent cyclase response element binding protein and elk-1 phosphorylation in the striatum. Neuroscience. 101:2000;607-617.
20. Crombag H.S., Jedynak J.P., Redmond K., Robinson T.E., Hope B.T. Locomotor sensitization to cocaine is associated with increased Fos expression in the accumbens, but not in the caudate. Behav Brain Res. 136:2002;455-462.
21. Curran E.J., Akil H., Watson S.J. Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain comparisons between acute drug treatment and a drug challenge in sensitized animals . Neurochem Res. 21:1996;1425-1435.
22. Cvejic S., Trapaidze N., Cyr C., Devi L.A. Thr353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down-regulation. J Biol Chem. 271:1996;4073-4076.
23. Deroche V., Marinelli M., Maccari S., Le Moal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids I . Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J Neurosci. 15:1995;7181-7188.
24. De Vries T.J., Schoffelmeer A.N., Binnekade R., Raaso H., Vanderschuren L.J. Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology. 26:2002;18-26.
25. Dwyer D.D., Bradley R.J., Kablinger A.S., Freeman A.M. Glucose metabolism in relation to schizophrenia and antipsychotic drug treatment. Ann Clin Psychiatry. 13:2001;103-113.
26. Elmer GI, Pieper JO, Rubinstein M, Low MJ, Grandy DK, Wise RA (2002) Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice. J Neurosci 15:RC224.
27. Gerfen C.R., Miyachi S., Paletzki R., Brown P. D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK 1/2/MAP kinase. J Neurosci. 22:2002;5042-5054.
28. 35S]GTPγS binding after haloperidol treatment. Eur J Pharmacol. 382:1999;119-127.
29. 35S]GTPγS binding. Life Sci. 65:1999;1633-1645.
30. 35S]GTPγS binding in striatum of 6-hydroxydopamine-lesioned rats. Brain Res. 841:1999;135-142.
31. 35S]GTPγS binding discrepancy with receptor binding profile . Eur J Pharmacol. 392:2000;125-128.
32. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
33. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA. 87:1990;6912-6916.
34. Hamamura T., Ichimaru Y. Amphetamine sensitization augments amphetamine-induced Fos expression in the lateral habenula. Brain Res. 767:1997;140-143.
35. Hanoune J., Defer N. Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol. 41:2001;145-174.
36. Hedou G., Jongen-Relo A.L., Murphy C.A., Heidbreder C.A., Feldon J. Sensitized Fos expression in subterritories of the rat medial prefrontal cortex and nucleus accumbens following amphetamine sensitization as revealed by stereology. Brain Res. 950:2002;165-179.
37. Hiroi N., White N.M. The amphetamine conditioned place preference differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas . Brain Res. 552:1991;141-152.
38. Hubner C.B., Moreton J.E. Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology. 105:1991;151-156.
39. Imperato A., Tanda G., Frau R., Di Chiara G. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther. 245:1988;257-264.
40. Johnston C.M., Hill C.S., Chawla S., Treisman R., Bading H. Calcium controls gene expression via three distinct pathways that can function independently of the ras/MAP kinases (ERKs) signalling cascade. J Neurosci. 17:1997;6189-6202.
41. Keefe K.A., Gerfen C.R. D1-D2 dopamine receptor synergy in striatum effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression . Neuroscience. 66:1995;903-909.
42. Kelley A.E., Berridge K.C. The neuroscience of natural rewards relevance to addictive drugs . J Neurosci. 22:2002;3306-3311.
43. LaHoste G.J., Henry B.L., Marshall J.F. Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials. J Neurosci. 20:2000;6666-6671.
44. Le Moine C., Svenningsson P., Fredholm B.B., Bloch B. Dopamine-adenosine interactions in the striatum and the globus pallidus inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression . J Neurosci. 17:1997;8038-8048.
45. Loxton N.J., Dawe S. Alcohol abuse and dysfunctional eating in adolescent girls the influence of individual differences in sensitivity to reward and punishment . Int J Eat Disord. 29:2001;455-462.
46. McBride W.J., Murphy J.M., Ikemoto S. Localization of brain reinforcement mechanisms intracranial self-administration and intracranial place-conditioning studies . Behav Brain Res. 101:1999;129-152.
47. Marshall J.F., Cole B.N., LaHoste G.J. Dopamine D2 receptor control of pallidal fos expression comparisons between intact and 6-hydroxydopamine-treated hemispheres . Brain Res. 632:1993;308-313.
48. oα in discrete regions of rat brain. J Neurochem. 55:1990;1079-1082.
49. Ortiz J., Fitzgerald L.W., Lane S., Terwilliger R., Nestler E.J. Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropsychopharmacology. 4:1996;443-452.
50. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1998;Academic Press, Sydney.
51. Pentney R.J., Gratton A. Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat an in vivo electrochemical study . Neuroscience. 45:1991;95-102.
52. Phillips T.J., Brown K.J., Burkhart-Kasch S., Wenger C.D., Kelly M.A., Rubinstein M., Grandy D.K., Low M.J. Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nat Neurosci. 1:1998;610-615.
53. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev. 25:1997;192-216.
54. Pontieri F.E., Tanda G., Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci USA. 92:1995;12304-12308.
55. Pothos E.N., Creese I., Hoebel B.G. Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J Neurosci. 15:1995;6640-6650.
56. Richtand N.M., Woods S.C., Berger S.P., Strakowski S.M. D3 dopamine receptor, behavioral sensitization, and psychosis. Neurosci Biobehav Rev. 25:2001;427-443.
57. Robertson G.S., Jian M. D1 and D2 dopamine receptors differentially increase fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience. 64:1995;1019-1034.
58. Robertson G.S., Vincent S.R., Fibiger H.C. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
59. Robinson T.E., Becker J.B., Priesty S.K. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine sex differences . Brain Res. 253:1982;231-241.
60. Rouge-Pont F., Marinelli M., Le Moal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids II . Sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion. J Neurosci. 15:1995;7189-7195.
61. Ruskin D.N., Marshall J.F. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats. Brain Res. 703:1995;156-164.
62. Simpson C.S., Morris B.J. Induction of c-fos and zif/268 gene expression in rat striatal neurons following stimulation of D1-like dopamine receptors, involves protein kinase A and protein kinase C. Neuroscience. 68:1995;97-106.
63. Slotkin T.A., Seidler F.J., Yanai J. Heroin neuroteratogenicity targeting adenylyl cyclase as an underlying biochemical mechanism . Dev Brain Res. 132:2001;69-79.
64. Starr M.S., Starr B.S. Behavioural synergism between the dopamine agonists SKF38393 and LY171555 in dopamine-depleted mice antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors . Pharmacol Biochem Behav. 33:1989;41-44.
65. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol. 4:1993;289-312.
66. Sulzer D., Maidment N.T., Rayport S. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem. 60:1993;527-535.
67. Szczypka M.S., Kwok K., Brot M.D., Marck B.T., Matsumoto A.M., Donahue B.A., Palmiter R.D. Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron. 30:2001;819-828.
68. Szczypka M.S., Mandel R.J., Donahue B.A., Snyder R.O., Leff S.E., Palmiter R.D. Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice. Neuron. 22:1999;167-178.
69. Turgeon S.M., Blum J.E., Auerbach E.A. Behavioral sensitization to amphetamine is not accompanied by a decrease in the number of c-Fos containing cells in the striatum. Brain Res. 782:1998;329-332.
70. Unterwald E.M., Fillmore J., Kreek M.J. Chronic repeated cocaine administration increase dopamine D-1 receptor-mediated signal transduction. Eur J Pharmacol. 318:1996;31-35.
71. Vincent S.R., Sebben M., Dumuis A., Bockaert J. Neurotransmitter regulation of MAP kinase signaling in striatal neurons in primary culture. Synapse. 29:1998;29-36.
72. Vossler M.R., Yao H., York R.D., Pan M.G., Rim C.S., Stork J.S. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell. 89:1997;73-82.
73. Wachtel S.R., Hu X.T., Galloway M.P., White F.J. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Synapse. 4:1989;327-346.
74. Wise R.A. Drug-activation of brain reward pathways. Drug Alcohol Dep. 51:1998;13-22.
75. Wise R.A., Munn E. Effects of repeated amphetamine injections on lateral hypothalamic brain stimulation reward and subsequent locomotion. Behav Brain Res. 55:1993;195-201.
76. Wolfe W.L., Maisto S.A. The relationship between eating disor-ders and substance use moving beyond co-prevalence research . Clin Psychol Rev. 20:2000;617-631.
77. Xu M., Hu X.T., Cooper D.C., Moratalla R., Graybiel A.M., White F.J., Tonegawa S. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell. 79:1994;945-955.
78. Xu M., Koeltzow T.E., Santiago G.T., Moratalla R., Cooper D.C., Hu X.-T., White N.M., Graybiel A.M., White F.J., Tonegawa S. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron. 19:1997;837-848.
79. Zeiders J.L., Seidler F.J., Slotkin T.A. Agonist-induced sensitization of β-adrenoceptor signaling in neonatal rat heart expression and catalytic activity of adenylyl cyclase . J Pharmacol Exp Ther. 291:1999;503-510.
80. Zhang J., Chiodo L.A., Freeman A.S. Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res. 590:1992;153-163.